RespireRx Pharmaceuticals Inc (CE) (RSPI) Quote

"The longs will still maintain, but will not be able to sell until RSPI returns from EM."
Sure they can, if they want to. It's buying that the brokers aren't permitting while in the EM.

Folks,
From all the comments in the last week or so, is this the (weird) scenario ?:
RSPI is receiving inquiries from “cash-rich pharma” as to partnering for 2 or more candidates which are showing excellent profiles in safety and efficacy. The RSPI principles, cognizant of how undervalued the RSPI stock is, decided to purposely go into the Expert Market and then once in, buy back as much stock as possible at ridiculous prices without involvement of the retail market. The longs will still maintain, but will not be able to sell until RSPI returns from EM. So, if I understand what many of you believe, when RSPI returns, the share price will be at least in the penny area, not mill.
I am confused. I understood the FDA completely shot down CX717 for ADHD, yet it is still in the pipeline.

Shii at 0.20 cents we all getting a million. Whiling to wait a year or so if I have to. Just a lil whiff of fda approval or nasqad partnership will get us there.

Both situations are entirely reasonable. Market cap closed at 900k dod funding was 1.8m 001-003 all those buys are going to make us look like we have Einstein intelligence when this emerges from EM pit. The run up going down in history books.

I would still be a multi millionaire lol

What if they get bought out for $6.27?

That's why I put up all my shares at 1$ per . One never knows in the EM market

This is an Investment. that means you have to trust the plan, the pipeline, the Ceo, the entity who invested 100k of his own $, And you need to be patient, these things take time. but at the end of the day, you bought shares in a company that you believed has something of value to offer in its pipeline. DoD forked over 1.8 mil in grant $ because they obviously see a potential. ignore the gnats, they are small minded, think large, This is an up and coming BioPharma Company, when it validates what it has, people will kick themselves for listening to the naysayers and bailing for chump change!!! Those who stood strong, will reap the rewards of their Risk! GLTA

Yes, suddenly very quiet today, following the 2 first days in the expert market which, perhaps surprisingly had much activity, price flip-flopping 0.0002 to 0.0011, and “quoted” briefly at 0.0012. Maybe there was some kind of intervention? They can only let people have so many shares (100s of thousands!) at 0.0002 or 0.0003, when it also trades at 0.001 and 0.0011 (in 100s of thousands as well). Hum, I got a few 100 thousands at 0.0003!

Mine for sale for a dollar a share ! Who knows lop

I have heard that the bid price must match the asking price. Also, the number of shares must match. People working in tandem with a telephone or the guy sitting on a computer in the adjacent seat can easily match these up and trade shares back and forth at very low prices to entice others to bail out of their investments. Thats why I say those cheap shares won't be bought by retail. All IMO, GLTA HB
PS> Seems the Microsoft outage is screwing up Schwab too.😫

I’m back out from suspension jail boyssss! Still holding 6m strong.

Whoever talking about going private just drop that noise. I asked Jeff about it last week. He couldn’t out right say yes or no for obvious reasons. But reaffirmed they pride themselves on being transparent with shareholders said previous 8-k would’ve been handled differently.

Also I asked was it a lapse in judgment that lead to us being on our way to EM. He inserted the generic template can’t give one on one investor advice. But added on he has been in investment banking sector for 28 years now. And 8-k’s will continue to be sent out if any new updates occur.

Looks all this is a concentrate effort already planned from the get go. Time will tell. Bullish as ever tho!

Well said and this is why I am here along with you and others who are looking at the bigger picture!

Any erratic volume on the EM is just that. The price essentially is meaningless at this point. Whether you are in or out has already been decided from a retail investor standpoint. There are always a few looking for scraps and trading those scraps, but anything of size has been decided.

Maybe if they start issuing PR's and 8-k's that provide detail on the go forward strategy and filings wrapping up imminently we might see some of those "sophisticated and professional" investors scoop up shares higher and higher before the company is re-launched back into public trading. When they do the shareprice will be considerably higher, just ask the strong critics who agree and have also stated that. The pipeline assets have not been questioned. They state they are seeking funding in 8-k, the CEO is looking to open purse strings and anyone with half a brain can understand they are at a stage needing investment support heading into likely 3 or more clinical trials in the next 3-9 months is my guess.

They also keyed in on discrete funding channels. The OSA program in Australia has multiple funding sources already lined up now since they seperated those assets from the RSPI entity. I would expect similar actions now with the AMPA and GABA programs. It makes sense right. DOD funding phase 2 for SCI and possibly using the drug for ADHD is a big deal. But that is different market size with different interested investors than say another BP focused on epilepsy or pain management. So that all makes sense. I think I am most curious if they split up AMPA and GABA programs and how. In my opinion KRM-ll-81 is premier exiting preclinicals. That asset would definitely make sense on another exchange. Pharmas are flush with cash. I suspect there are probably many merger candidates flush with cash but failed trials looking for assets to continue drug discovery business. I can see RSPI spin out additional assets rewarding all equity stakeholders in the process with a piece of the pie. There are plenty of paths for sure they can take with this tremendous pipeline. For my money, the shoe fits here. I intend to just tuck these shares away for the long run. I think timing wise with SCI phase 2 upcoming in Q4, we are going to hear more sooner than later. RSPI will want to capitalize on progress and funding/BP sources will want to entertain staking a position before valuation continues to rise as this pipeline progresses. Good luck to all. Enjoy your summer.

Any erratic volume on the EM is just that. The price essentially is meaningless at this point. Whether you are in or out has already been decided from a retail investor standpoint. There are always a few looking for scraps and trading those scraps, but anything of size has been decided.

Maybe if they start issuing PR's and 8-k's that provide detail on the go forward strategy and filings wrapping up imminently we might see some of those "sophisticated and professional" investors scoop up shares higher and higher before the company is re-launched back into public trading. When they do the shareprice will be considerably higher, just ask the strong critics who agree and have also stated that. The pipeline assets have not been questioned. They state they are seeking funding in 8-k, the CEO is looking to open purse strings and anyone with half a brain can understand they are at a stage needing investment support heading into likely 3 or more clinical trials in the next 3-9 months is my guess.

They also keyed in on discrete funding channels. The OSA program in Australia has multiple funding sources already lined up now since they seperated those assets from the RSPI entity. I would expect similar actions now with the AMPA and GABA programs. It makes sense right. DOD funding phase 2 for SCI and possibly using the drug for ADHD is a big deal. But that is different market size with different interested investors than say another BP focused on epilepsy or pain management. So that all makes sense. I think I am most curious if they split up AMPA and GABA programs and how. In my opinion KRM-ll-81 is premier exiting preclinicals. That asset would definitely make sense on another exchange. Pharmas are flush with cash. I suspect there are probably many merger candidates flush with cash but failed trials looking for assets to continue drug discovery business. I can see RSPI spin out additional assets rewarding all equity stakeholders in the process with a piece of the pie. There are plenty of paths for sure they can take with this tremendous pipeline. For my money, the shoe fits here. I intend to just tuck these shares away for the long run. I think timing wise with SCI phase 2 upcoming in Q4, we are going to hear more sooner than later. RSPI will want to capitalize on progress and funding/BP sources will want to entertain staking a position before valuation continues to rise as this pipeline progresses. Good luck to all. Enjoy your summer.

Keep trying Jus, this will stay on EM for months, you have time on your side to buy up those low trips.

not sure if you are being sarcastic or not lol

Maybe management decided that with the economy guru's and echoe chambers predicting a market crash, that the Expert Markets are a safe place to be while the dust settles, knowing their incredible pipeline and value that each drug holds, they did not want to give control over to the market manipulators.

Very well said! I couldn't agree more! I expect our value to significantly increase while we are on the expert market! I am so glad that I am locked in here with a 7.5 million share position. I could care less about the short-term expert market quotes. I could care less what the naysayers, or I told you, so folks spout off here.
I too know what we are holding here with this incredible pipeline!

Cheers!!!

Being mainly for the science I am having trouble figuring just what the hell is going on right now. For a time, I didn't know what "EM" was, and when I figured it out, if I will lose it all when RSPI entered EM. I will say it again, this company IMO has an incredible pipeline. If what I suspect for the ampakines turns out, even with almost a billion shares, we should in the dollar/shr range. But as I said, I am a scientist ...

I put 14 mil .0003 bid but nothing fill

I am willing to bet that not many are getting anything of decent size in the trips. One thing about being on the expert market is it could trade at .0001 and the very next trade be at .01 cent. I rode a stock up on the greys before there was an expert market that went from sub pennies to over $1.30 while it was on the greys. I made some incredible profits on that trade back in 2019. That is just the nature of the beast. Now if folks are going to sell for tax losses and place a market order then some lucky Canadians might get some cheap shares. Other than that nobody who is holding at this point is willing to give anything up. I know that I am not selling anytime soon!

Just put a bunch of bids in for .0001, 2, 3, 4, 5 and see what u get! 🤣 IMO, those shares down there are not for retail consumption.

Told ya

Cheer! I can't get .0003

B. 460,000 .0003
A. 330,000 .0010

And what gives you standing to be paid any attention to?

Move on Newbie... save your breath...

RSPI on Expert Market. No quotes for us.

Why is this showing no bid and no ask on Charles Schwab?

TIA

$RSPI is a gem for Canadians that can get bargain prices. Cheers to you Canadian!

You all can try and explain this away..
But, a pig is a pig, no matter how much lipstick you you dress it up with..
$RSPI is a PIG!!!
EM is never a good thing, STOP trying to justify your long positions.
Move on, why waste your time on this POS!!!
Denial is expected when faced with a total disaster, you longs are seriously sick..

They are still EM. So far, even with the recent 10k and Q filings nothing has changed for them. Let's keep an eye on them.

The arithmetic is the arithmetic. but this is a courtesy, not a debt.

That arithmetic doesn't makes sense to me. The exercise price for the warrants is $0.0015. Can you explain further how his deal set up a strong disincentive against dilution? The 33,333,333 shares don't connect to the $10,000.

As for Dr Nasiek, do the arithmetic, this amounts to ~0.003$ sp, so going below will upset the good Doctor.

The info refresh is unreliable, most of the time it’s “-/-“. But it will flicker, or flash a figure on occasion. So I use other sources to get a more confident guess.

"I have to look around, but I can get info that allows me to make educated guesses"
Do I understand you to mean that they DON'T publish bid and asked prices?
In the US brokers can't, but the Expert Market doesn't prohibit trading and the publication of trade data, from which one might "make educated guesses" before placing their sell orders.


You've said this 5 times. Can you tell me what you mean by it?
"Dr Nasiek deliberately set up a strong disincentive against dilution"
"The Purchase Agreement is with the Dariusz Nasiek and Sara Nasiek, JTTEN and identified a $100,000.00 loan in the form of a Demand Promissory Note and a Warrant exercisable into 33,333,333 shares of RespireRx Common Stock. "

Thanks for all the feedback.

Yes Canadian here, I have been a RBC customer 40 years. The app interface refresh is not super, and I have to look around, but I can get info that allows me to make educated guesses. I will visit RBCI offices in Montreal to get some advice. It’s all very friendly.

Thanks for the comeback. Seems like you may have a leg up on this.
Are you a Canadian resident?
Does RBCI publish bid and asked prices?

This is real man, Canada welcomes you!

Absolutely! O Canada, The True North strong and free! I can trade this. I tested this by slapping it to 0.0011, and buying at 0.0002. However buying so low resulted in instant slapping back to 0.001 by someone else. The stock traded in the EM throughout the day. I’m looking forward to this. I am guessing I may be allowed to trade as a pre-existing shareholder, and I’ve done that before with other stocks.

No kidding right wow what a steal

Any chance you used Royal Bank of Canada Investing to try and place a buy order today?

Hey! Do we have anyone here from Canada or has access to the bid / ask quotations on the Expert Market???
For those of you wondering my volume today (by price) says:
475,500 @ .0002
630,000 @ .0008
1,439,000 @.001
15,000 @ .0011 (close price)
I wouldn't get too excited about who got .0002's or even .0008's. It's probably the same tomfoolery that was going on with GSTM before EM- the MM's still swapping shares to artificially drop the PPS, IMO. GLTA, HB.

Try buy .0003 but no fill

Yes typo .. 0.0002 some lucky guy?

Typo? Daily Range - .0002 to .0011.
Daily range 0.002 - 0.0010 .. wow

Now this is a thing of beauty. Classic pump and dump that trapped several well known pumpers. Exactly what the pumpers deserve who are trapped in this worthless shit.

Daily range 0.002 - 0.0010 .. wow

I would think that would be part of the plan to rebuild some trust and set a precendent of integrity and communication.

There are plenty (almost all) of stakeholders with equity, so liquidity will matter sooner than later and as mentioned, drug development requires liquidity at all phases as it progresses along to spread risk as well as grow investor base/support levels. Now maybe... They spin out the EndeavourRx assets into a brand new company with funding and all stakeholders get a piece of that enormous pie. Leaving Resolution Rx (OSA assets) to trade on the OTC and Australian exchange. The past filings indicate aiming for something similar to open finance channels for individual drug efforts. Maybe even split out the AMPA and GABA programs into seperate entities as well?? They are at this exact point for all pipeline assets and announced they are seeking funding and looking at structure; so maybe best to be EM at the moment and avoid the gyrations of the OTC that can lead to unwanted shenanagins. I am not sure how some can completely ignore the progress and value of the assets... Yet even some critics claim; going to zero while also stating if they would have filings out or PR'd more in different order this would we well into the pennies!! The assets that can drive this "well into the pennies" are still there and if anything indications are they have increased in value significantly and are a slam dunk to head into multiple clinical trials... I think it is good advice to enjoy the summer and be patient for updates coming as they navigate the future paths for this outstanding pipeline. My hunch is purse strings are sitting at the table....

btw. the chart looks good for a huge reversal once they come out of EM >> bottom player!